NSE · LASA
Lasa Supergenerics Limited
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#3,846
of 5,096 stocks
Operating in Healthcare, Lasa Supergenerics Limited is seeing revenue contract sharply, has a subdued return on equity, and has promoters holding 54%.
Market Cap
28.06 Cr
P/E Ratio
—
P/B Ratio
0.57
ROE
-68.70%
ROCE
-69.14%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 1.23 Cr | -13.15 L | 2.20 Cr | 3.06 Cr |
| Net Profit | -3.58 Cr | -4.16 Cr | -2.55 Cr | -6.25 Cr |
| EPS | 0.71 | -0.83 | -0.51 | -1.25 |
| Operating Profit | -2.86 Cr | -3.85 Cr | -2.30 Cr | -5.56 Cr |
Shareholding pattern
Promoter
53.65%
Public
46.35%
Mutual fund holdings
Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 20 Sep 2024 | Other | Annual General Meeting |
| 20 Sep 2023 | Other | Annual General Meeting |
| 16 Sep 2022 | Dividend | Annual General Meeting/Dividend - Re 0.25 Per Share |
| 15 Sep 2021 | Dividend | Annual General Meeting/Dividend - Rs 0.25 Per Share |
| 17 Sep 2020 | Other | Annual General Meeting |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.